Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: Lane3 who wrote (164714)	5/19/2020 2:53:35 PM
From: i-node	Read Replies (1) \| Respond to of 361693

No one infects anyone with HCQ in the course of a clinical trial.

To: Lane3 who wrote (164714)	7/24/2020 3:16:25 PM
From: Lane3	Read Replies (1) \| Respond to of 361693

Old business: Opinion by Editorial Board July 23, 2020 at 4:04 p.m. EDT THE NOVEL coronavirus is inflicting global suffering that is likely to persist until scientists produce an effective vaccine. With so much hinging on a vaccine, some are calling for a little-known epidemiological tool to speed testing: human challenge trials. Under certain conditions, human challenge trials — in which individuals volunteer to be deliberately exposed to a pathogen — could hasten vaccine development by giving scientists rapid feedback about what is and isn’t working. Given the pandemic’s mounting destruction, proposals that could set the world on a path to recovery sooner — even risky proposals — should be considered............. washingtonpost.com